Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Current Drug Therapy

Reducing the risks when using benzodiazepines to treat insomnia: A public health approach

Vania Modesto-Lowe, MD, MPH, Margaret M. Chaplin, MD, Roberto León-Barriera, MD and Lakshit Jain, MD
Cleveland Clinic Journal of Medicine May 2024, 91 (5) 293-299; DOI: https://doi.org/10.3949/ccjm.91a.23061
Vania Modesto-Lowe
Department of Psychiatry, University of Connecticut, Farmington, CT; Medical Director, Hartford Behavioral Health, Hartford, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret M. Chaplin
Department of Psychiatry, University of Connecticut, Farmington, CT; Farrell Treatment Center, New Britain, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto León-Barriera
Assistant Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lakshit Jain
Assistant Clinical Professor, Department of Psychiatry, University of Connecticut, Farmington, CT; Connecticut Valley Hospital, Middletown, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 91 no. 5 293-299
DOI 
https://doi.org/10.3949/ccjm.91a.23061
PubMed 
38692699

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online May 1, 2024.

Copyright & Usage 
Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Vania Modesto-Lowe, MD, MPH
  1. Department of Psychiatry, University of Connecticut, Farmington, CT; Medical Director, Hartford Behavioral Health, Hartford, CT
  1. Margaret M. Chaplin, MD
  1. Department of Psychiatry, University of Connecticut, Farmington, CT; Farrell Treatment Center, New Britain, CT
  1. Roberto León-Barriera, MD
  1. Assistant Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA
  1. Lakshit Jain, MD⇑
  1. Assistant Clinical Professor, Department of Psychiatry, University of Connecticut, Farmington, CT; Connecticut Valley Hospital, Middletown, CT
  1. Address:
    Lakshit Jain, MD, Department of Psychiatry, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06457; lakshit.jain{at}ct.gov

Cited By...

  • 2 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 91 (5)
Cleveland Clinic Journal of Medicine
Vol. 91, Issue 5
1 May 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
Vania Modesto-Lowe, Margaret M. Chaplin, Roberto León-Barriera, Lakshit Jain
Cleveland Clinic Journal of Medicine May 2024, 91 (5) 293-299; DOI: 10.3949/ccjm.91a.23061

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
Vania Modesto-Lowe, Margaret M. Chaplin, Roberto León-Barriera, Lakshit Jain
Cleveland Clinic Journal of Medicine May 2024, 91 (5) 293-299; DOI: 10.3949/ccjm.91a.23061
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • A PUBLIC HEALTH APPROACH
    • PRIMARY PREVENTION: PRESCRIBE BENZODIAZEPINES JUDICIOUSLY
    • SECONDARY PREVENTION: KEEP THE DURATION OF USE SHORT
    • TERTIARY PREVENTION: STOPPING AFTER LONG-TERM USE
    • CONCLUSION
    • DISCLOSURES
    • Acknowledgment
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Nonstatin therapy to reduce low-density lipoprotein cholesterol and improve cardiovascular outcomes
  • A practical guide for buprenorphine initiation in the primary care setting
Show more Current Drug Therapy

Similar Articles

Subjects

  • Drug Therapy
  • Mental Health
  • Sleep Medicine

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire